跳至主要内容
临床试验/NCT02541214
NCT02541214已完成不适用

Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea in New Zealand

Fisher and Paykel Healthcare4 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2015年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
39
试验地点
4
主要终点
Subjective measurements of comfort on the trial Nasal Mask gathered through a custom questionnaire

研究概览

简要总结

Currently, Fisher and Paykel Healthcare (FPH) is developing a new nasal mask.

This investigation is designed to evaluate the performance of the trial nasal mask, focused specifically on how the different seal sizes will perform on Obstructive Sleep Apnea participants who are currently on Positive Airway Pressure therapy.

Participant's prescribed treatment pressure with their usual mask will be collected for 7 days ± 3 days prior to mask fitting with the trial nasal mask. They will then be issued with the trial nasal mask to use in-home for 14 days ± 4 days.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with Ostructive Sleep Apnea by a practicing physician or clinicans
  • Existing nasal or nasal pillows user
  • Prescribed Positive Airway Pressure therapy (Bi-Level or Continuous Positive Airway Pressure (CPAP) or Automatic Positive Airway Pressure (APAP))

排除标准

  • Inability to give informed consent
  • Pregnant or think they may be pregnant
  • Anatomical or physiological conditions making Positive Airway Pressure therapy inappropriate (e.g unconsolidated facial fracture)
  • Patients who are in a coma or decreased level of consciousness
  • Current diagnosis of CO2 retention
  • Commercial Drivers who are investigated by New Zealand Transport Agency (NZTA)

研究组 & 干预措施

Trial Nasal Mask

Experimental

The participant will use the Saturn nasal mask for 2 weeks in home

干预措施: Trial Nasal Mask (Device)

结局指标

主要结局

Subjective measurements of comfort on the trial Nasal Mask gathered through a custom questionnaire

时间窗: 2 weeks in home

次要结局

  • Preference of the Trial Nasal mask compared to the participant's usual mask through a custom questionnaire.(2 weeks in home)
  • Seal performance of the trial Nasal mask as measured by the subjective perception of leak through a custom questionnaire, in addition to objective leak data and treatment efficacy through the Positive Airway Pressure therapy device.(2 weeks in home)
  • Objective leak data through the Positive Airway Pressure therapy device(2 weeks in home)
  • Treatment efficacy through the Positive Airway Pressure therapy device(2 weeks in home)

研究者

发起方
Fisher and Paykel Healthcare
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验